Table 1

Clinico-pathological characteristics of the overall series, and percentage of cases with positive CD133 expression

Characteristics

No. pts (%)

No. (%) of cases with positive CD133 expression

p valuea


All cases

160

50 (31.2)


Age (yrs)

<65

113 (70.6)

36 (31.9)

≥ 65

47 (29.4)

14 (29.8)

0.8


FIGO Stage

I-II

20 (12.5)

6 (30.0)

III

119 (74.4)

39 (32.8)

IV

21 (13.1)

5 (23.8)

0.7


Grade

G1-2

28 (17.4)

7 (25.0)

G3

107 (66.8)

34 (31.8)

0.5

n.a.

35 (21.8)


Histotype

Serous

115 (71.9)

33 (28.7)

Other

45 (28.1)

17 (40.5)

0.2


Residual tumor

Absent

52 (32.5)

19 (36.5)

Suboptimal

40 (25.0)

8 (20.0)

Exploratory laparotomy

68 (42.5)

23 (33.8)

0.2


Response to treatment

Yes

130 (81.2)

43 (33.1)

No

30 (18.8)

7 (23.3)

0.3


acalculated by Fisher's exact test for proportion or X2 test

n.a. = not available

Ferrandina et al. BMC Cancer 2009 9:221   doi:10.1186/1471-2407-9-221

Open Data